Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer.

Fong L, Hotson A, Powderly JD, Sznol M, Heist RS, Choueiri TK, George S, Hughes BGM, Hellmann MD, Shepard DR, Rini BI, Kummar S, Weise AM, Riese MJ, Markman B, Emens LA, Mahadevan D, Luke JJ, Laport G, Brody JD, Hernandez-Aya L, Bonomi P, Goldman JW, Berim L, Renouf DJ, Goodwin RA, Munneke B, Ho PY, Hsieh J, McCaffery I, Kwei L, Willingham SB, Miller RA.

Cancer Discov. 2020 Jan;10(1):40-53. doi: 10.1158/2159-8290.CD-19-0980. Epub 2019 Nov 15.

2.

Changes in infaunal assemblage structure influence nutrient fluxes in sediment enriched by mussel biodeposition.

Lacoste É, Weise AM, Lavoie MF, Archambault P, McKindsey CW.

Sci Total Environ. 2019 Nov 20;692:39-48. doi: 10.1016/j.scitotenv.2019.07.235. Epub 2019 Jul 16.

PMID:
31336300
3.

First-in-human, phase I study of PF-06647263, an anti-EFNA4 calicheamicin antibody-drug conjugate, in patients with advanced solid tumors.

Garrido-Laguna I, Krop I, Burris HA 3rd, Hamilton E, Braiteh F, Weise AM, Abu-Khalaf M, Werner TL, Pirie-Shepherd S, Zopf CJ, Lakshminarayanan M, Holland JS, Baffa R, Hong DS.

Int J Cancer. 2019 Oct 1;145(7):1798-1808. doi: 10.1002/ijc.32154. Epub 2019 Feb 23.

PMID:
30680712
4.

New options for the adjuvant treatment of cutaneous melanoma?

Weise AM, Flaherty LE.

Curr Oncol Rep. 2014 Nov;16(11):409. doi: 10.1007/s11912-014-0409-x. Review.

PMID:
25286906
5.

New options in the management of intractable ALK(+) metastatic non-small-cell lung cancer.

Weise AM, Gadgeel S.

Lung Cancer (Auckl). 2014 Aug 6;5:35-42. doi: 10.2147/LCTT.S50414. eCollection 2014. Review.

6.

Relationship between propagule pressure and colonization pressure in invasion ecology: a test with ships' ballast.

Briski E, Bailey SA, Casas-Monroy O, DiBacco C, Kaczmarska I, Levings C, MacGillivary ML, McKindsey CW, Nasmith LE, Parenteau M, Piercey GE, Rochon A, Roy S, Simard N, Villac MC, Weise AM, MacIsaac HJ.

Proc Biol Sci. 2012 Aug 7;279(1740):2990-7. doi: 10.1098/rspb.2011.2671. Epub 2012 Mar 28.

7.

Possible case of levofloxacin-induced thrombocytopenia.

Salloum R, Liu CY, Weise AM.

Am J Health Syst Pharm. 2011 Jan 1;68(1):43-6. doi: 10.2146/ajhp090564.

PMID:
21164064
8.

Intratumoral DNA electroporation induces anti-tumor immunity and tumor regression.

Radkevich-Brown O, Piechocki MP, Back JB, Weise AM, Pilon-Thomas S, Wei WZ.

Cancer Immunol Immunother. 2010 Mar;59(3):409-17. doi: 10.1007/s00262-009-0760-1.

9.

Fatal liver failure in a patient on acetaminophen treated with sunitinib malate and levothyroxine.

Weise AM, Liu CY, Shields AF.

Ann Pharmacother. 2009 Apr;43(4):761-6. doi: 10.1345/aph.1L528. Epub 2009 Mar 31.

PMID:
19336648
10.

Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression.

Fu J, Weise AM, Falany JL, Falany CN, Thibodeau BJ, Miller FR, Kocarek TA, Runge-Morris M.

Breast Cancer Res Treat. 2010 Feb;120(1):35-45. doi: 10.1007/s10549-009-0363-8. Epub 2009 Mar 24.

11.

Her-2 DNA versus cell vaccine: immunogenicity and anti-tumor activity.

Whittington PJ, Radkevich-Brown O, Jacob JB, Jones RF, Weise AM, Wei WZ.

Cancer Immunol Immunother. 2009 May;58(5):759-67. doi: 10.1007/s00262-008-0599-x. Epub 2008 Oct 3.

Supplemental Content

Loading ...
Support Center